Albert Bourla's tweet - "This week a shipment of @Pfizer patented medicines & vaccines to treat & prevent life-threatening infectious diseases, inflammatory disease & certain cancers arrived in #Rwanda under An Accord for a Healthier World. We are working together to close the #healthequity gap! "

@AlbertBourla | 57,865 followers

This week a shipment of @Pfizer patented medicines & vaccines to treat & prevent life-threatening infectious diseases, inflammatory disease & certain cancers arrived in #Rwanda under An Accord for a Healthier World. We are working together to close the #healthequity gap!

Ministry of Health | Rwanda

@RwandaHealth

The Ministry of Health has received eight categories of Pfizer medicines and vaccines for infectious and inflammatory diseases and certain cancers through ‘An Accord for a Healthier World’ signed between the Government of Rwanda and @pfizer. pic.twitter.com/W0pyKzWwck

Engagement Map

Quotes

Replies

Retweets

Replies and Quotes

Total of 6 replies and 0 quotes found

In reply to @AlbertBourla

Luciana

@lucianabglx

When will the final documentation regarding the vaccination of children from 6 months against Covid be delivered to Anvisa?Please, we request urgently! Brazilian children are at risk, because they have no protection against Covid! @minsaude @vacinapedcovid

In reply to @AlbertBourla

spectrumsts

@spectrumsts1

Good luck, Rwanda! You will need it.

In reply to @AlbertBourla

NOT_an_NPC

@NPCish

Demon! You’ll burn in the Lake of Fire

In reply to @AlbertBourla

K9 Tracker S&R

@TrackerK9

“Pfizer was mastering or let's say we had very good experience & expertise w/multiple technologies that could give a vaccine. RNA was the technology that we had less experience with, only 2 years working on this. (Continued Below)

Over 2 replies and quotes not shown

Retweeters

No retweeters found

7 retweeters not shown

For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.

Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.

Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.